key: cord-0903795-q0k8t1yg
authors: Campagna, Bianca R.; Tutino, Rebecca; Stevanovic, Kristina; Flood, Julia; Halevi, Gali; Shemesh, Eyal; Annunziato, Rachel A.
title: Acceleration of mobile health for monitoring post‐transplant in the COVID‐19 era: Applications for pediatric settings
date: 2021-10-18
journal: Pediatr Transplant
DOI: 10.1111/petr.14152
sha: 61f20422f671f6265507ee02ae4c473ced8344e2
doc_id: 903795
cord_uid: q0k8t1yg

BACKGROUND: Since the start of the COVID‐19 pandemic and consequent lockdowns, the use of telehealth interventions has rapidly increased both in the general population and among transplant recipients. Among pediatric transplant recipients, this most frequently takes the form of interventions on mobile devices, or mHealth, such as remote visits via video chat or phone, phone‐based monitoring, and mobile apps. Telehealth interventions may offer the opportunity to provide care that minimizes many of the barriers of in‐person care. METHODS: The present review followed the PRISMA guidelines. Sources up until October 2020 were initially identified through searches of PsycInfo(®) and PubMed(®). RESULTS: We identified ten papers that reported findings from adult interventions and five studies based in pediatrics. Eight of the adult publications stemmed from the same two trials; within the pediatric subset, this was the case for two papers. Studies that have looked at mHealth interventions have found high acceptability rates over the short run, but there is a general lack of data on long‐term use. CONCLUSIONS: The literature surrounding pediatric trials specifically is sparse with all findings referencing interventions that are in early stages of development, ranging from field tests to small feasibility trials. The lack of research highlights the need for a multi‐center RCT that utilizes robust measures of medication adherence and other outcome variables, with longer‐term follow‐up before telehealth interventions should be fully embraced.

The potential benefits of telehealth were rapidly accepted during the pandemic, but their scope may apply beyond the current public health crisis. Telehealth may serve as a convenient and feasible option for delivering post-transplant care to pediatric solid organ recipients and could offer many benefits over traditional in-person care beyond its necessity during the pandemic. It can fill accessibility gaps in rural areas and underserved communities where there may not be an adequate number of qualified providers 6 and may reduce the burden of care on patients and their caregivers. Telehealth minimizes the need for transportation access, which disproportionately affects individuals of low socioeconomic status, and is quite relevant to the transplant context as access to centers may require long commutes. Individuals with accessibility barriers may not receive consistent care, which adversely affects health outcomes.

Telehealth also comes with its own set of barriers depending on the type of service utilized. A recent study of telehealth use during the COVID-19 pandemic found that patients over 65 years old had the lowest odds of utilizing telehealth services versus office or emergency room visits. 7 This may be relevant for pediatric patients with caregivers who experience difficulties utilizing telehealth services for care. For video-conferencing, patients must have access to a stable internet connection, which may not be the case for many families. To this point, one survey found that among individuals making less than $30 000 USD per year, 29% did not own a smartphone, and 44% did not have broadband services. 8 Accessibility should therefore also be considered when evaluating the use of telehealth.

An important but often neglected aspect of telehealth is a dearth of findings demonstrating its comparability to standard care. As in any new approach to care, embracing new technologies without appropriate testing could lead, in the long run, to provision of more expensive and less efficient care-the exact opposite of the intended outcomes. Other interventions that seemed on the surface conducive to streamlining care have yielded mixed findings. One example of this is related to the premature embrace of the EHR. Without any appropriate pre-vetting or research, EHRs were touted as a vehicle to increase efficiency of care, reduce costs, and reduce medication errors. Yet, the wide embrace of EHR did not lead to any of those hoped-for outcomes, and EHRs are now routinely cited as one of the top factors associated with physician burnout. 9,10 More specifically in transplant medicine, although many electronic and automated interfaces have been suggested and promoted to increase and facilitate engagement with patients and families, almost none of those have been rigorously studied. At the same time, it is important to acknowledge the potential of these types of interventions and our aim is to synthesize available literature to date in order to better understand the applicability of telehealth to pediatric transplant.

The present review focuses on the use of telehealth in monitoring of post-transplant outcomes including, but not limited to, self-reported adherence, QoL, patient self-reported symptoms, and medical outcomes, and explore how it may apply it to the pediatric population. The purpose of the this paper is to provide an empirical, nuanced examination of the potential benefits and drawbacks to telehealth established by prior work as well as important future directions to guide clinicians on its delivery.

The present synthesis was based on a systematic review following the PRISMA guidelines. 11 The procedures that were followed are described below and outlined in Figure 1.

We aimed to cast a wide net to exhaustively canvas studies investigating monitoring in transplant patients. Therefore, all empirical research designs were included such as RCTs, controlled trials (not randomized), cohort studies, observational cohort studies, pre-post comparisons, and retrospective chart reviews. Articles were excluded if they did not report on an intervention or monitoring (e.g., only adherence was discussed).

Sources up until October 2020 were initially identified through searches of PsycInfo ® and PubMed ® . We used only information provided in the published articles and did not use any other external sources (i.e., we did not look at grant proposals or registration materials and did not contact the authors for details that were not presented in published manuscripts).

Sample electronic database search strategy: PubMed title/abstract: "Telehealth" AND "transplant," filters activated: Humans, English.

Three authors (BRC, RT, and RAA) separately screened article titles produced by the search strategy described above. First, article titles were reviewed, and abstracts were then examined for articles that did not meet the exclusion criteria based on the title and content.

Full-text articles were reviewed for studies that appeared to meet eligibility criteria based on the abstract. One author (RAA) independently reviewed the selected studies to confirm eligibility.

The following data were collected from each article that reported on an intervention approach: sample size, demographic data, study design, intervention description, and the results.

The inclusion of only published results can result in loss of negative or neutral findings. We also found that on multiple occasions, the same study was described in multiple papers. In order to minimize bias, we have consolidated results and also captured a wide range of design choices to provide a more nuanced summary in terms of generalizability.

Our first step was to examine the utility of telehealth for monitoring generally in transplantation. We identified ten papers that reported findings from adult interventions and five studies based in pediatrics. Of note, eight of the adult publications stemmed from the same two trials; within the pediatric subset, this was the case for two papers. Findings are summarized in Table 1 . were collected on the acceptability of technology as well as usage.

Overall, the intervention group displayed significantly lower readmission rates 90 days post-discharge (28% vs. 58%) as well as better QoL in the domains of physical functioning and general health than those receiving SOC only.

In Germany, a similar approach has been successfully conducted as well. 13 One of the main auspices of Pocket PATH ® is to facilitate improved self-management, and this includes consistent monitoring. Results suggested better self-management in the intervention group, but there were no differences in the clinical outcomes assessed.

Despite the recent emergence of mHealth technologies for the management of pediatric chronic medical conditions, 20-22 few studies have explored the use of mHealth in the pediatric transplant population. One study described the development and testing of an mHealth application, Teen Pocket PATH ® , an iteration of the Pocket PATH ® application tailored to adolescents. 16 The authors suggest preliminary usability and efficacy in prompting adolescents to adhere to their medications. Another study utilized a mHealth application in conjunction with other forms of digital medicine: a wearable patch and an ingestible sensor pill that relayed health information to the app and care team. 17 The study showed promise in terms of positive patient satisfaction with the intervention and positive selfreports of medication adherence. However, there were extremely high levels of attrition for a multitude of reasons, including irritability from the skin patch. 17 Another intervention developed is the TRU-PBMT App, which is used in conjunction with an apple watch in order to monitor patient symptoms. 18 The TRU-PBMT intervention is currently being studied for feasibility, acceptability, and usability. 23, 24 Thus, the development of mHealth interventions for the pediatric transplant population is in its early stages.

To date, only two other studies have utilized telehealth in the pediatric transplant population without the use of mHealth apps. In addition, it was found that most had a positive attitude toward features that facilitated greater accessibility, such as automatic data transfer to their clinics and the inclusion of visual aids. In this study, the use of websites was preferred over a smartphone application, though at the time of completion, few of the participants owned smartphones. Similar findings were found in a 2018 study whose sample had a mean age of 51.8 (SD = 14.2 years). 29 The authors argued that younger individuals could potentially benefit from telehealth more than older individuals due to their higher affinity toward technology. These aspects of telehealth may be especially relevant for older caretakers who may be less likely to utilize technology.

Reports generally show that patients do use mHealth interfaces-at least for a brief period of time. While long-term use remains unexplored, the shorter-term studies have reported high rates of acceptability. 31 In one study, 75% of the participants approached to join the study agreed to participate. 14 Kelly et al. 19 found that among adolescents who were part of a group-based telehealth intervention aiming to increase medication adherence, 85.7% of participants were satisfied with the use of technology, 78.6% would use telehealth in the future, and 85.7% would recommend using telehealth to a friend. A study of adults, with an average age of 57 (SD = 14), found that 80% of participants rated highly the perceived usefulness of mobile apps. 32 Other studies have reported similar findings. 14,24,33 Patients may, thus, be willing to use telehealth monitoring and interventions post-transplant, but persistence in using such apps/devices or interventions, beyond the initial novelty, has yet to be established.

The economic cost of telehealth may be much less than that of traditional in-person care. 34, 35 One study compared the cost of telehealth to in-person postoperative visits which included the cost of travel, accommodations, meals, and missed work. 34 Telehealth may also be effective at reducing cost for health systems when it is adjacent to in-person visits rather than a replacement for visits. 36 One study in kidney transplant recipients compared the cost of standard care versus standard care with the addition of telehealth supported case management in 46 patients during the first

year post-transplant. 36 The authors found that the addition of the telehealth component yielded a non-statistically significant savings of €1944 (USD $2352) per patient for hospitals due to a reduction in care utilization. The authors estimated that this would amount to € 791 033 (USD $957 071) if implemented in the 12 German hospitals doing more than 20 transplants a year. Thus, telehealth may present cost-savings for multiple stakeholders.

The COVID-19 outbreak has caused major shifts in routine health- Recent studies have suggested that the use of telehealth appointments was feasible for transplant recipients during the COVID-19 pandemic. 5, [39] [40] [41] [42] This modality was well received by patients, as it curbs risk of infection and removes the hassles of transportation, parking, and wait times. 40, 43 One study also suggested that accessing care from home was more comfortable for patients. 43 Transplant clinics have also uncovered unexpected benefits from the use of telehealth, such as the ability to frequently check-in on patients with acute medical and surgical issues and the ability to reinforce education as needed. 44 One clinic has even incorporated telehealth robots for in-person appointments to minimize the spread of COVID-19 among liver transplant patients, and reports confidence in this approach. 45 Telehealth could thus offer a range of benefits for the transplant community, particularly via the reduction of transmission rates, patient burden, and cost. Given these potential benefits and the promising feasibility of telehealth, it is possible that these shifts precipitated by the COVID-19 pandemic will be everlasting for the transplant community.

Although telehealth has burgeoned in the COVID-19 era, there are still very few empirical studies to support its usage for monitoring and key methodological issues germane to adherence research have not been well covered. However, there are promising findings to draw from. Shorter-term monitoring studies have yielded positive outcomes, utilizing mobile phone apps, telehealth-based case management, and group-based cognitive behavioral therapy interventions. 12, 13, 15 Also promising, given the context of the COVID-19

pandemic, one study found that those who participated in telehealth visits versus in-person visits did not have significantly different outcomes. 46 Telehealth interventions may offer the opportunity to provide care that minimizes many of the barriers of in-person care.

Monitoring that includes additional resources may also be more suc- Accordingly, specific to app-based interventions and monitoring, studies that only measure short-term outcomes are severely limited in generalizability. Improvements in adherence achieved in the first

year of app use were not sustained, and given current results, it is quite possible that app-based interventions may not be engaging over a long period. A meta-analysis of app-based interventions for various chronic illnesses found a pooled dropout rate of 43%. 48 The short-term benefits of telehealth for monitoring may not be sustainable if the intervention or monitoring protocol is unable to facilitate ongoing participation.

Studies have found high acceptability rates over the short run, but findings to date are drawn from a handful of studies that may not generalize well given design considerations and short follow-up or, reliance on self-report measures rather than actual use metrics.

In both adult and pediatric trials, findings were reported in the context of small sample sizes 13, 14, 17, 19, 24 and a lack of long-term outcomes. [12] [13] [14] 16, 17, 24 Additionally, almost all trials were single-center trials, which may result in patient homogeneity in terms of race and socioeconomic status and consequently a lack of generalizability.

Many of these studies, both adult and pediatric trials, made use of self-report and collateral measures, 12 The previously mentioned limitations of this field highlight the need for a multi-center RCT that utilizes robust measures of medication adherence and other outcome variables, with longer-term follow-up. It is expected that the use of telehealth for post-transplant monitoring will continue to grow as a result of COVID-19 as many clinics are shifting to virtual appointments when possible. Telehealth could offer a wide range of benefits, but both history and current findings should give some pause to anyone who is willing to embrace new technology without scrutiny. We owe it to our patients to study promising technologies before they are implemented, and our reading of the literature is that whenever telehealth interventions were rigorously tested (which is not often), they failed to show the intended (hopeful) outcome and fell quite short of initial expectations.

Perhaps one way to move forward, until more data are available, is to reduce expectations. Rather than looking at telehealth applications as a new panacea for improved care, we suggest framing these approaches as potential additions, yet unproven, to post-transplant care, that may offer some circumscribed benefits at a relatively acceptable cost.

BRC: Concept/design, data collection, data analysis/interpretation, drafting article, critical revision of article, approval of article; RT:

Concept/design, data collection, data analysis/interpretation, draft- 

No original data were collected for the present review.

Eyal Shemesh https://orcid.org/0000-0003-2508-3423

Rachel A. Annunziato https://orcid.org/0000-0002-2665-6097

Global Diffusion of EHealth: Making Universal Health Coverage Achievable: Report of the Third Global Survey on EHealth

World Health Organization (WHO). mHealth: Use of Mobile Wireless Technologies for Public Health. World Health Organization

COVID-19 transforms health care through telemedicine: Evidence from the field

In-person outreach and telemedicine in liver and intestinal transplant: a survey of national practices, impact of coronavirus disease 2019, and areas of opportunity

Optimising the use of telemedicine in a kidney transplant programme during the coronavirus disease 2019 pandemic

Addressing health disparities in rural communities using telehealth

Characteristics of telehealth users in NYC for COVID-related care during the coronavirus pandemic

Digital divide persists even as lower-income Americans make gains in tech adoption

Electronic health records and clinician burnout: a story of three eras

Electronic health records: a critical appraisal of strengths and limitations

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Telemedicine based remote home monitoring after liver transplantation: results of a randomized prospective trial

Telemedically supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial

Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients

A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation

Development and field testing of Teen Pocket PATH ® , a mobile health application to improve medication adherence in adolescent solid organ recipients

Digital medicine program with pediatric solid organ transplant patients: perceived benefits and challenges

Customization of the TRU-PBMT App (Technology Recordings to better Understand Pediatric Blood and Marrow Transplant)

Implementing a home-based telehealth group adherence intervention with adolescent transplant recipients

Use of personal digital assistants by adolescents with severe asthma: can they enhance patient outcomes? AACN Clin Issues Adv Pract Acute Crit Care

iCanCope with Pain TM : usercentred design of a web-and mobile-based self-management program for youth with chronic pain based on identified health care needs

Real-world evaluation of a mobile health application in children with asthma

A protocol to assess feasibility, acceptability, and usability of mobile technology for symptom management in pediatric transplant patients

Mobile health technology for pediatric symptom monitoring: a feasibility study

The KTx360°-study: a multicenter, multisectoral, multimodal, telemedicine-based follow-up care model to improve care and reduce health-care costs after kidney transplantation in children and adults

Liver transplant recipients' experiences and perspectives of a telehealth-delivered lifestyle programme: a qualitative study

Patient satisfaction and healthcare utilization using telemedicine in liver transplant recipients

Technology experience of solid organ transplant patients and their overall willingness to use interactive health technology: interactive health technology in transplantation

Mobile technology affinity in renal transplant recipients

Evaluation of a telehealth solution developed to improve follow-up after kidney transplantation

Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial

Acceptance and use of mobile technology for health self-monitoring in lung transplant recipients during the first year post-transplantation

A mobile app (mHeart) to detect medication nonadherence in the heart transplant population: validation study

Health economic analysis of postoperative video telemedicine visits to patients' homes

Outcomes of telehealth care for lung transplant recipients

Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation-a budget impact analysis from the healthcare perspective

Pediatric transplantation in Europe during the COVID-19 pandemic: early impact on activity and healthcare

Notification of Enforcement Discretion for telehealth remote communications during the COVID-19 nationwide public health emergency

Telehealth in outpatient management of kidney transplant recipients during COVID-19 pandemic in New York

Video Consultation during the COVID-19 pandemic: a single center's experience with lung transplant recipients

Following-up allogeneic transplantation recipients during the COVID-19 pandemic

Management of transplant patients outside hospital during COVID-19 epidemic: a Chinese experience

Transition of a large tertiary heart failure program in response to the COVID-19 pandemic: changes that will endure

Practice change amidst the COVID-19 pandemic: harnessing the momentum for expanding telehealth in transplant

Technological innovation in outpatient assistance for chronic liver disease and liver transplant patients during the coronavirus disease outbreak: a method to minimize transmission

Infection, rejection, and hospitalizations in transplant recipients using telehealth

Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients

Rates of attrition and dropout in app-based interventions for chronic disease: systematic review and meta-analysis

A systematic review of immunosuppressant adherence interventions in transplant recipients: decoding the streetlight effect

Acceleration of mobile health for monitoring post-transplant in the COVID-19 era: Applications for pediatric settings